Saints Row

Apr 09, 2019

VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report

Apr 09, 2019

VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics

Mar 15, 2019

VolitionRx Limited to Present at Conferences in the U.S. Next Week

Nov 07, 2018

VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update

Oct 04, 2018

VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics

Aug 01, 2018

VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today

Jul 02, 2018

Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region

May 09, 2018

VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits

Mar 07, 2018

VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board

Sep 21, 2017

VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding

Aug 03, 2017

VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update

Jun 27, 2017

VolitionRx Limited Corrects an Earlier Announcement